Hememics Biotechnologies, Inc.

Gaithersburg, MD Doing business as HBI

UEI
EU9ES2TT3KN1
CAGE
4QB41
Primary NAICS
541990 All Other Professional, Scientific, and Technical Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Self Certified Small Disadvantaged Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
401 Professional Dr #220, Gaithersburg, MD 20879, USA
Website
hememics.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Grant awards

SBA capabilities narrative

HEMEMICS is a privately-held, development and manufacturing company. The company's signature discovery, HemSol, is a proprietary desiccation solution that solves the preservation, storage and shipping problems involving dehydrating and rehydrating nucleic acids, proteins, cells and tissues. The company has been successful in stabilizing and maintaining biologics on the silicon chips for biosensor applications. HEMEMICS is currently focused on delivering a rapid, point-of-care, biosensor that detects antibodies and antigens in under 60 seconds. HEMEMICS' HemBoxTM will allow first responders to 'rule-in/rule-out' exposure to pathogens on site, helping to manage the spread of infectious disease epidemics. This will improve the management and decrease the spread of infectious diseases. With its networking capability, the HemBoxTM can instantly relay data from the field to data centers to efficiently identify and manage disease clusters.

Quick answers

Is Hememics Biotechnologies, Inc. registered in SAM.gov?

Yes. Hememics Biotechnologies, Inc.'s SAM.gov registration is active through August 30, 2027.

What is Hememics Biotechnologies, Inc.'s most recent federal award?

Hememics Biotechnologies, Inc.'s most recent federal contract award is Hememics hembox: a rapid, point-of-care diagnostic tool for novel viruses (75A50120C00074), from Office of the Assistant Secretary for Preparedness and Response, on April 9, 2020.

On GovTribe

See Hememics Biotechnologies, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors